Infrared illumination for difficult peripheral venous catheterisation in critically ill adult patients: the prospective, randomised, multicentre ICARE trial

医学 重症监护医学 随机对照试验 外科 急诊医学
作者
R. Ouedraogo,Aline da Silva Alves,Amélie Bruant,Oumar Sy,Cécilia Tabra Osorio,Frédérique Schortgen,Amélie Chenal,Damien Contou,Laurence Krzyzaniak,Muriel Fartoukh,Marianne Le Joncour,Nicolas Mongardon,L. Benaïssa,Daniel Da Silva,Meriem Bouguerra,Sophie Demeret,Stéphanie Dubois,Eric Starczala,Chirine Petyt,Matthieu Schmidt,Séverine Dezellus,Jean Francois Georger,Ann-Cécile Pallud,Damien Carras,Fabien Boussely,Étienne Audureau,Armand Mekontso Dessap
出处
期刊:BMJ Open [BMJ]
卷期号:15 (2): e090611-e090611
标识
DOI:10.1136/bmjopen-2024-090611
摘要

Introduction The insertion of a peripheral venous line is of paramount importance in the stabilisation of critically ill patients. It is a preferred method of venous access over more invasive techniques due to its immediacy and fewer complications. Difficulties of catheterisation can result in delays to treatment, increased complication risks and pain, and a waste of valuable time and healthcare resources. Our hypothesis is that infrared vein illumination could improve the success rate of peripheral venous catheterisation in critically ill patients at risk of difficult catheterisation. Methods and analysis This is a prospective, multicentre, randomised, open-label controlled trial. It will be conducted in France and will involve critically ill patients at risk of difficult peripheral catheterisation. Patients will be randomly assigned to usual care or infrared vein illumination. The primary outcome is the rate of successful peripheral venous catheterisation at first puncture. Secondary outcomes include time to placement, overall rate of successful peripheral venous catheterisation, number of punctures, quality (calibre of the catheter), replacement rate, need for central line and local complications (dysfunction, diffusion, haematoma and lymphangitis). Ethics and dissemination The study has been granted ethical approval (CPP Ile de France 1). Following the provision of informed consent, patients will be included in the study. The results will be submitted for publication in peer-reviewed journals. Trial registration number NCT03932214 .

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim应助mensa采纳,获得10
刚刚
蒋清仪完成签到 ,获得积分10
刚刚
xyzlancet完成签到,获得积分10
刚刚
贪玩的秋柔应助风清扬采纳,获得30
2秒前
2秒前
4秒前
Jasper应助meteor采纳,获得10
6秒前
慕青应助杨文静采纳,获得10
6秒前
6秒前
霖宸羽完成签到,获得积分10
6秒前
我补药写论文啊呜呜呜完成签到,获得积分10
7秒前
zzz完成签到,获得积分10
8秒前
xxxx完成签到 ,获得积分10
10秒前
科研通AI6.3应助张棋欢采纳,获得10
10秒前
犹豫惜萱发布了新的文献求助10
10秒前
liuyepiao完成签到,获得积分10
12秒前
科研通AI6.1应助盲点采纳,获得10
12秒前
molihuakai应助小万采纳,获得10
13秒前
傲娇蜻蜓完成签到,获得积分10
13秒前
小巧曼容完成签到,获得积分10
13秒前
化学天空完成签到,获得积分10
15秒前
16秒前
我太饿了发布了新的文献求助10
16秒前
SciGPT应助guoyunlong采纳,获得10
16秒前
18秒前
20秒前
20秒前
ckj完成签到 ,获得积分10
20秒前
哈哈发布了新的文献求助10
21秒前
向日葵完成签到,获得积分10
22秒前
23秒前
YC完成签到,获得积分10
24秒前
zzztsing0213发布了新的文献求助10
24秒前
Hello应助达达采纳,获得10
24秒前
山狮子完成签到 ,获得积分10
24秒前
24秒前
25秒前
25秒前
情怀应助AAA顺其自然采纳,获得10
26秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
How to Design and Conduct an Experiment and Write a Lab Report: Your Complete Guide to the Scientific Method (Step-by-Step Study Skills) 333
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6363382
求助须知:如何正确求助?哪些是违规求助? 8177252
关于积分的说明 17232206
捐赠科研通 5418431
什么是DOI,文献DOI怎么找? 2867043
邀请新用户注册赠送积分活动 1844285
关于科研通互助平台的介绍 1691794